Lucira Health Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
163
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$36.4M
Lucira Health General Information
Description
Operator of a medical technology company intended to develop COVID-19 home test kits. The company provides an over-the-counter product that puts 2-in-1 lab testing to determine if your viral respiratory symptoms are caused by COVID-19 and the flu.
Contact Information
Website
www.lucirahealth.comCorporate Office
- 1315 63rd Street
- Emeryville, CA 94608
- United States
Corporate Office
- 1315 63rd Street
- Emeryville, CA 94608
- United States
Lucira Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 20-Apr-2023 | $36.4M | Completed | Generating Revenue | ||
| 13. Bankruptcy: Admin/Reorg | 22-Feb-2023 | Completed | Bankruptcy: Admin/Reorg | |||
| 12. IPO | 05-Feb-2021 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series C) | 01-Aug-2020 | Completed | Generating Revenue | |||
| 10. Grant | 22-Apr-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 06-Mar-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series 1) | 01-Mar-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 01-Jul-2018 | Completed | Generating Revenue | |||
| 6. Grant | 06-Feb-2017 | $4.32M | $12.9M | Completed | Generating Revenue | |
| 5. Grant | 25-Jan-2017 | $1.49M | $12.9M | Completed | Startup |
Lucira Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 14,115,898 | $0.001000 | $1.19 | $1.19 | 1x | $1.19 | 10.22% |
Lucira Health Comparisons
Industry
Financing
Details
Lucira Health Competitors (17)
One of Lucira Health’s 17 competitors is Rheonix, a Venture Capital-Backed company based in Ithaca, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rheonix | Venture Capital-Backed | Ithaca, NY | ||||
| BioGenex Laboratories | Corporation | Fremont, CA | ||||
| Idexx Laboratories | Formerly VC-backed | Westbrook, ME | ||||
| T2 Biosystems | Formerly VC-backed | Lexington, MA | ||||
| ChipCare | Formerly VC-backed | Toronto, Canada |
Lucira Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lucira Health Patents
Lucira Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022051694-A1 | Streamlined assay preparation | Inactive | 04-Sep-2020 | ||
| WO-2022051694-A9 | Streamlined assay preparation | Inactive | 04-Sep-2020 | ||
| CA-199403-S | Assay device with lcd display | Active | 03-Jun-2020 | ||
| WO-2020180858-A1 | Bubble-free liquid filling of fluidic chambers | Inactive | 05-Mar-2019 | ||
| WO-2020180858-A8 | Bubble-free liquid filling of fluidic chambers | Inactive | 05-Mar-2019 | B01L3/502 |
Lucira Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lucira Health Former Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 11.2 Capital | Venture Capital | Minority | ||
| 412 Venture Fund | Venture Capital | Minority | ||
| Bee Cave Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| DCVC | Venture Capital | Minority |
Lucira Health ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
15.64 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Lucira Health FAQs
-
When was Lucira Health founded?
Lucira Health was founded in 2012.
-
Where is Lucira Health headquartered?
Lucira Health is headquartered in Emeryville, CA.
-
What is the size of Lucira Health?
Lucira Health has 163 total employees.
-
What industry is Lucira Health in?
Lucira Health’s primary industry is Diagnostic Equipment.
-
Is Lucira Health a private or public company?
Lucira Health is a Private company.
-
What is the current valuation of Lucira Health?
The current valuation of Lucira Health is .
-
What is Lucira Health’s current revenue?
The current revenue for Lucira Health is .
-
How much funding has Lucira Health raised over time?
Lucira Health has raised $257M.
-
Who are Lucira Health’s investors?
11.2 Capital, 412 Venture Fund, Bee Cave Capital, , and DCVC are 5 of 24 investors who have invested in Lucira Health.
-
Who are Lucira Health’s competitors?
Rheonix, BioGenex Laboratories, Idexx Laboratories, T2 Biosystems, and ChipCare are some of the 17 competitors of Lucira Health.
-
When was Lucira Health acquired?
Lucira Health was acquired on 20-Apr-2023.
-
Who acquired Lucira Health?
Lucira Health was acquired by Pfizer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
